Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $190.84 million as of February 5, 2026. Its market cap has increased by 145.29% in one year.

• Market Cap: 190.84M
• Enterprise Value: 305.37M
• 1-Year Change: 145.29%
• Ranking: #3853
• Category: Micro-Cap
• Stock Price: $2.96

Market Cap Chart

Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $190.84M, an increase of 78.69%. That is a compound annual growth rate of 2.62%.

Market Cap History

Date	Market Cap	% Change
Feb 3, 2026	209.50M	-21.89%
Dec 31, 2025	268.20M	231.11%
Dec 31, 2024	81.00M	-21.13%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	-15.92%
Sep 10, 2003	106.80M	-

View and export this data all the way back to 2003. Sign Up Today.

Related Stocks

Company	Market Cap
Voyager Therapeutics	217.40M
Nuvectis Pharma	217.21M
Inhibikase Therapeutics	216.12M
Minerva Neurosciences	213.34M
Sagimet Biosciences	213.34M
Tonix Pharmaceuticals Holding	212.64M
Tharimmune	212.28M
SAB Biotherapeutics	211.85M